KRAS and cancer: It is important to highlight that the RPE1 cells used in this study, although telomerase immortalized and non‐transformed (Bodnar et al, 1998), do still have mutations in at least two known cancer‐associated genes: CDKN2A and KRAS (Di Nicolantonio et al, 2008; Libouban et al, 2017).